Identification of MiR-93-5p Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation

Figure 13

The Kaplan–Meier survival analysis of the gene signature. (a) IGF2, (b) IGFBP3, (c) ACTR2, (d) SLC2A4, (e) IGF1R, and (f) YWHAB.

(a)

(b)

(c)

(d)

(e)

(f)